As hyperglycemia, insulin resistance, and hyperlipidemia are major contributors to DCM in T2D [1,2,3,4,5], we further explored whether FGF21 could mitigate heart damage in T2D mice. This evidence concerns the gene FGF21 and familial dilated cardiomyopathy.